Browsing Tag
Pharmaceutical Industry
42 posts
AstraZeneca posts strong Q1 2024 results with significant revenue and EPS growth
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679…
April 29, 2024
Lilly announces significant results in SURMOUNT-OSA trials of tirzepatide in OSA
Eli Lilly and Company (NYSE: LLY) has released positive topline results from the phase 3 SURMOUNT-OSA clinical trials,…
April 21, 2024
Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global…
March 20, 2024
Zydus Lifesciences gains FDA approval for Finasteride and Tadalafil Capsules
In a significant development for the pharmaceutical industry, Zydus Lifesciences Limited, previously known as Cadila Healthcare Limited, has…
March 17, 2024
Eris Lifesciences acquires Biocon Biologics’ branded formulation business for Rs 1,242cr
In a strategic move that reshapes the landscape of India’s injectables market, Eris Lifesciences Ltd., a leading player…
March 14, 2024
Strides Pharma Science secures FDA approval for Gabapentin tablets
In a notable advancement for neuropathic pain treatment, Strides Pharma Science Limited (Strides) has announced that its step-down…
March 6, 2024
Venus Remedies receives significant boost with PLI Scheme disbursement
Venus Remedies Ltd, a leading player in India’s generic drug manufacturing sector, has recently been awarded a pivotal…
March 6, 2024
Bajaj Healthcare forges CDMO agreement with UK/EU clients for API supply
Bajaj Healthcare Ltd., a prominent figure in the pharmaceutical industry specializing in the manufacturing of Active Pharmaceutical Ingredients…
February 28, 2024
Lupin Limited announces satisfactory FDA inspection results for Mandideep facility
Global pharmaceutical major, Lupin Limited (Lupin), has announced receiving the Establishment Inspection Report (EIR) from the United States…
November 1, 2023
Nordic Capital proposes $846m acquisition of Advanz Pharma
In a significant move within the pharmaceutical industry, Nordic Capital has made a formal offer to acquire Advanz…
January 27, 2021